Actinium Pharmaceuticals vs Shattuck Labs
Shattuck Labs is the larger business, with $1.0m of revenue in fiscal 2025 against $90,000 for Actinium Pharmaceuticals (11.1 times as much). Actinium Pharmaceuticals grew faster (11.1% against -82.5%). Shattuck Labs kept more of each dollar of sales as profit: a net margin of -4880.9% against -37652.2%.
| Latest fiscal year | Actinium PharmaceuticalsATNM, 2025 | Shattuck LabsSTTK, 2025 |
|---|---|---|
| Revenue | $90,000 | $1.0m |
| Revenue growth | 11.1% | -82.5% |
| Net income | −$33.9m | −$48.8m |
| Operating margin | — | -5150.8% |
| Net margin | -37652.2% | -4880.9% |
| Return on equity | -153.3% | -60.3% |
| Free cash flow | −$24.7m | −$40.0m |
| Cash | $48.0m | $54.2m |
| Total debt | $0 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 25 | 40 |
| Market value | $44.8m | $546m |
| Price vs our value range | — | — |
| Moat score | — | 12 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 1 buys, 6 sales |